HDAC modulator (Souvien Therapeutics/Juvenescence)

N/A

Report date: 2025/03/20 14:45:11
NME

Base Information

Drug NameHDAC modulator (Souvien Therapeutics/Juvenescence)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase modulators
TargetsHistone deacetylase
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBritish Virgin Islands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJuvenescence Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJuvenescence LtdSouvien Therapeutics
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A